Image de couverture de livre

The use of opioids nine months after surgery for Crohn's disease – a nationwide cohort study

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Bente Mertz Nørgård, Caroline Thingholm Thorarinsson, Floor Dijkstra Zegers, Jens Kjeldsen, Rahul S. Dalal, Ken Lund, Torben Knudsen
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Alimentary Pharmacology & Therapeutics
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Research Communication: Combination Therapy of Upadacitinib With Infliximab, Risankizumab, Ustekinumab or Vedolizumab for Refractory Crohn's Disease: A Descriptive Case Series
par: Rahul S. Dalal, et autres
Publié: (2025)

The persistence of chronic opioid use in patients with inflammatory bowel disease—A nationwide cohort study
par: Bente Mertz Nørgård, et autres
Publié: (2025)

Editorial: Surgery to reduce opioid use in Crohn's disease: Does a classic solution address a newer problem?
par: Tarun Chhibba
Publié: (2024)

Editorial: Upadacitinib in Perianal Crohn's Disease
par: Manjeet Kumar Goyal, et autres
Publié: (2026)

Treatment of inflammatory bowel disease with steroid‐sparing medications is age‐dependent – Results from a Danish nationwide cohort study, 2000–2018
par: Rie Louise Møller Nordestgaard, et autres
Publié: (2024)

Metabolic dysfunction‐associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study
par: Yewan Park, et autres
Publié: (2024)

Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound
par: Cathy Lu, et autres
Publié: (2024)

Letter: Bowel Preparation Quality in Patients With Crohn's Disease
par: Tamar Schildkraut, et autres
Publié: (2024)

Letter: Addressing opioid exposure and associated harms in patients with IBD
par: Christian P. Selinger, et autres
Publié: (2024)

Letter: Crohn's Disease or Comorbidity? Reassessing Opioid Prescribing Patterns
par: Kuan‐Ju Lin, et autres
Publié: (2025)

Performance of bowel preparation quality scales in patients with Crohn's disease
par: Virginia Solitano, et autres
Publié: (2024)

Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis
par: Antoine Meyer, et autres
Publié: (2025)

Higher Prescribed Opioid Use Among Adults With Crohn's Disease Than General Population: A Nationwide Cohort Study in Sweden 2006–2021
par: Mehdi Osooli, et autres
Publié: (2025)

The Impact of Postoperative Prophylactic Medication on Long‐Term Surgical, Severe Endoscopic and Endoscopic or Radiologic Recurrence Following Primary Ileocecal Resection in Patients With Crohn's Disease
par: Sebastiaan ten Bokkel Huinink, et autres
Publié: (2025)

Editorial: Upadacitinib—A Promising Induction Agent for Paediatric Crohn's Disease?
par: Vincenzo Stranges, et autres
Publié: (2025)

Editorial: The prevalence and outcomes of perianal Crohn's disease across treatment eras
par: Daniel Tassone, et autres
Publié: (2024)

Letter: Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis
par: Zhidong Zhou, et autres
Publié: (2025)

Letter: Bowel Preparation Quality in Patients With Crohn's Disease—Authors' Reply
par: Virginia Solitano, et autres
Publié: (2024)

Editorial: Seton Use in Perianal Fistulising Crohn's Disease. Authors' Reply
par: Jeffrey D McCurdy, et autres
Publié: (2025)

Editorial: Examining Perianal Fistulising Crohn's Disease Through the Lens of Wound Repair
par: Tim Eglinton
Publié: (2025)

Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study
par: Shlomi Cohen, et autres
Publié: (2025)

Editorial: Real‐World Evidence of Upadacitinib—An Effective Induction Therapy for Crohn's Disease?
par: C. Ramos‐Belinchon, et autres
Publié: (2025)

Letter: The Simple Endoscopic Score for Predicting Crohn's Disease Progression—Not as Simple as It Sounds
par: Ziheng Calvin Xu, et autres
Publié: (2025)

Editorial: Mesenchymal Stem Cell Therapy for Perianal Fistulising Crohn's Disease—Effective or Hype?
par: Jeffrey D McCurdy, et autres
Publié: (2024)

Editorial: Endoscopic Activity is an Essential Tool for Patients' Management, Even in Mild Crohn's Disease
par: Marco Mendolaro, et autres
Publié: (2025)

Editorial: Infliximab induction therapy in pediatric Crohn's disease—A cost‐effective strategy?
par: Neil Chanchlani, et autres
Publié: (2024)

Letter: Putting Crohn's Risk Prediction to Work in Perianal Fistula—Calibration, Thresholds, and Transport
par: Emmanuel Pio Pastore
Publié: (2025)

Editorial: Beyond Resection—Rethinking Postoperative Management in Colonic Crohn's Disease. Authors' Reply
par: José Luis Rueda García, et autres
Publié: (2026)

One‐Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real‐World GETAID Study
par: Nicolas Richard, et autres
Publié: (2026)

Letter: Gut microbiota—An overlooked therapeutic target in the prevention of post‐operative recurrence of Crohn's disease
par: D. Bogatic, et autres
Publié: (2024)

Early ileal resection in Crohn's disease is not associated with severe long‐term outcomes: The ERIC study
par: Nathan Grellier, et autres
Publié: (2024)

Editorial: Real‐World Evidence of Upadacitinib—An Effective Induction Therapy for Crohn's Disease? Authors' Reply
par: Nicolas Richard, et autres
Publié: (2025)

Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulizing Crohn's Disease
par: Runqi Wang, et autres
Publié: (2026)

Letter: ‘Early Ileal Resection in Crohn's Disease Is Not Associated With Severe Long‐Term Outcomes: The ERIC Study’
par: Matthias Kelm, et autres
Publié: (2025)

Network Meta‐Analysis: Comparative Efficacy of Biologics and Small Molecules in the Induction and Maintenance of Remission in Crohn's Disease
par: Mohammad Shehab, et autres
Publié: (2025)

Letter: Extreme diagnostic delay due to misdiagnosis of gastrointestinal tuberculosis later diagnosed as postoperative Crohn's disease
par: Abhirup Chatterjee, et autres
Publié: (2024)

Letter: Re‐Examining Seton Efficacy in Perianal Crohn's Disease—Considerations for Outcome Measurement and Clinical Interpretation
par: Dingsheng Liu, et autres
Publié: (2025)

Editorial: Infliximab induction therapy in paediatric Crohn's disease — A cost‐effective strategy? Authors' reply
par: Stephanie A. Vuijk, et autres
Publié: (2024)

Crohn's Disease With Latent Tuberculosis Infection or Intestinal Tuberculosis: Rapid Discrimination by Targeted Next‐Generation Sequencing
par: Lingna Ye, et autres
Publié: (2025)

Editorial: “Striding” Towards Transmural Healing: Redefining Deep Remission as a Treatment Target in Crohn's Disease
par: Rohita Reji, et autres
Publié: (2026)